PAVmed (NASDAQ:PAVM – Get Rating) and Quipt Home Medical (NASDAQ:QIPT – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, risk, earnings, dividends, institutional ownership, profitability and valuation.

Earnings and Valuation

This table compares PAVmed and Quipt Home Medical's gross revenue, earnings per share and valuation.

Quipt Home Medical has higher revenue and earnings than PAVmed. PAVmed is trading at a lower price-to-earnings ratio than Quipt Home Medical, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares PAVmed and Quipt Home Medical's net margins, return on equity and return on assets.

Volatility & Risk

PAVmed has a beta of 0.88, indicating that its share price is 12% less volatile than the S&P 500. Comparatively, Quipt Home Medical has a beta of 0.6, indicating that its share price is 40% less volatile than the S&P 500.

Institutional and Insider Ownership

14.0% of PAVmed shares are owned by institutional investors. Comparatively, 26.1% of Quipt Home Medical shares are owned by institutional investors. 13.2% of PAVmed shares are owned by company insiders. Comparatively, 4.2% of Quipt Home Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current recommendations and price targets for PAVmed and Quipt Home Medical, as provided by MarketBeat.com.

PAVmed currently has a consensus price target of $3.56, suggesting a potential upside of 884.39%. Quipt Home Medical has a consensus price target of $11.75, suggesting a potential upside of 81.33%. Given PAVmed's higher possible upside, research analysts plainly believe PAVmed is more favorable than Quipt Home Medical.

Summary

Quipt Home Medical beats PAVmed on 10 of the 14 factors compared between the two stocks.

About PAVmed

(Get Rating)

PAVmed, Inc. is a commercial-stage technology medical device company, which engages in the commercialization of medical technologies. It operates through the following divisions: Medical Devices, Diagnostics, Digital Health, and Emerging Innovations. Its products include cell collection devices, esophageal DNA tests, carpal tunnel release, implantable intraosseous vascular access devices, and antimicrobial resorbable ear tubes. The company was founded on June 26, 2014 and is headquartered in New York, NY.

About Quipt Home Medical

(Get Rating)

Quipt Home Medical Corp. provides in-home medical equipment and supplies, and respiratory and durable medical equipment in the United States. It offers management of various chronic disease states focusing on patients with heart and pulmonary disease, sleep apnea, reduced mobility, and other chronic health conditions. The company also provides bariatric equipment, bathroom safety products, bilevel positive airway pressure, canes/crutches, continuous positive airway pressure, CPAP masks and accessories, hospital beds, humidifiers, nebulizers and compressors, oxygen concentrators, patient lifts, walkers, wheelchairs, and products for wound care. In addition, it offers ventilators; home-based sleep apnea and chronic obstructive pulmonary disease treatments; home-based healthcare logistics and services; medical supplies, medical equipment, mobility equipment, and respiratory equipment; and CPAP and BiPAP units, ventilation equipment and aids, daily and ambulatory aides, and equipment solutions, as well as home and hospital delivery, and oxygen therapy services. The company was formerly known as Protech Home Medical Corp. and changed its name to Quipt Home Medical Corp. in May 2021. Quipt Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.

Receive News & Ratings for PAVmed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PAVmed and related companies with MarketBeat.com's FREE daily email newsletter.